Lear stock jumps 11% as Q4 results, 2026 cash-flow guide put buybacks back in focus

Lear stock jumps 11% as Q4 results, 2026 cash-flow guide put buybacks back in focus

New York, Feb 4, 2026, 14:55 (EST) — Regular session.

Lear Corp shares jumped roughly 11% to $132.94 in afternoon trading Wednesday following the release of its fourth-quarter results and 2026 outlook in a regulatory filing. (SEC)

The update arrives as parts manufacturers approach 2026 facing slightly reduced production forecasts, with investors ready to penalize any margin slip. S&P Global Mobility’s January report trimmed North America’s 2026 light-vehicle production forecast by 0.8%. (S&P Global)

This shifts the focus squarely onto companies’ statements about costs and cash flow, rather than just their past quarter’s performance. Traders are clearly viewing guidance as the key takeaway.

Lear reported a 5% rise in fourth-quarter revenue, hitting $6.0 billion. Adjusted earnings per share, excluding restructuring and other special charges, increased to $3.41 from $2.94. However, free cash flow — operating cash after capital expenditures — dropped to $281 million from $489 million a year earlier. Looking ahead to 2026, Lear expects net sales between $23.21 billion and $24.01 billion, with free cash flow forecasted at $550 million to $650 million. The company also projected core operating earnings, a proprietary profit measure, between $1.03 billion and $1.2 billion. Lear assumes global industry production will decline 1% on a Lear sales-weighted basis and said its forecast excludes potential impacts from future tariff changes or production disruptions. (Lear Corporation)

The stock’s jump isn’t just tied to the income statement. Investors are also weighing how much of the cost cutting can be repeated.

On the earnings call, CFO Jason Cardew told analysts that at the midpoint of the 2026 outlook, Lear expects “year-over-year increases across the board.” He added the company aims to repurchase more than $300 million in shares that year. CEO Ray Scott highlighted key business wins despite ongoing industry and macroeconomic challenges, citing a two-year core sales backlog of $1.325 billion for 2026-2027. (The Motley Fool)

Other auto-parts stocks climbed in afternoon trading, led by seat maker Adient, which jumped nearly 12%. Aptiv and Magna both added around 4%.

Lear reported finishing the quarter with around $775 million left on its share buyback authorization, about 13% of its current market value. Since starting the program in 2011, the company has bought back $5.9 billion in stock. (SEC)

Yet the guidance relies on automaker timelines that can change quickly, plus steady trade policies and supply chains. Any bigger slip in production or a sudden tariff shock would squeeze cash flow forecasts and challenge how much margin gains actually stem from “self-help.”

The next update for suppliers will stem from automakers’ forecasts, kicking off with Ford, which plans to revise its financial outlook during its February 10 earnings call. Stellantis follows, aiming to release its full-year 2025 results on February 26. (Reuters)

Stock Market Today

  • Eric Johnson Announces 2026 UK Texaphonic Tour Dates
    February 4, 2026, 3:28 PM EST. Legendary Grammy-nominated guitarist Eric Johnson will embark on an 11-date UK tour in July and August 2026, marking his first return to Europe in over a decade. Johnson, known for his platinum-selling 1990 album 'Ah Via Musicom' and the Grammy-winning track 'Cliffs of Dover', has maintained a prolific career spanning over 40 years with 17 albums and numerous collaborations. The Texaphonic tour, featuring blues rock power trio material, follows extensive touring in the US, including the Experience Hendrix and G3 Reunion tours, and will conclude in the UK at the 'Guitar Dreams' festival in Scotland before a special event in Austin with Tommy Emmanuel.
AST SpaceMobile (ASTS) stock slides as AT&T taps Amazon Leo for satellite broadband
Previous Story

AST SpaceMobile (ASTS) stock slides as AT&T taps Amazon Leo for satellite broadband

AbbVie stock drops after Rinvoq sales miss, even as 2026 profit forecast tops estimates
Next Story

AbbVie stock drops after Rinvoq sales miss, even as 2026 profit forecast tops estimates

Go toTop